Oncology Imaging
CoreLab Partners is the most experienced imaging core lab in oncology drug development research. We have successfully partnered with global industry leaders to assist them in bringing to market, life-enhancing oncology drugs in a timely, cost-efficient manner.
Tumor Expertise
- Basal Cell
- Bladder
- Bone Mets
- Breast
- Colon
- Colorectal
- Gastric
- GIST (GI stromal tumors)
- Glioblastoma Multiforme
- Head and Neck
- Liver
- Lung (small & nonsmall cell)
|
- Lymphoma
- Melanoma
- Multiple Myeloma
- Neuroendocrine
- Ovarian
- Pancreatic
- Prostate
- Renal Cell
- Sarcoma
- Solid Tumors
- Thyroid
|
Expert Oncology Review
CoreLab Partners’ board-certified radiologists read all radiographic and photographic images frombaseline to completion and provide blinded, in-depth oncology response review.
Response Evaluation – Lesion Measurement
CoreLab Partners continually refines and enhances our technological and regulatory expertise, staying conversant with current industry techniques and assessment criteria standards including:
- RECIST and RECIST 1.1
- Cheson (1996, 1999, 2007)
- WHO
- Macdonald
- EBMT
- CHOI
- EORTC (Young, 1999)
- Volumetric Assessment
- RANO
- PERCIST
|